American Society of Hematology

Hematologic Drug Shortage Information


Updated on: June 24, 2015

ASH continues to work with Congress, federal agencies, and other stakeholders to ensure continued access to safe and effective hematologic drugs.

New Updates on Hematologic Drug Shortages

FDA Reports Supply Issue with Cytarabine Injection
On March 13, the FDA informed ASH of a potential supply issue for cytarabine injection.  The FDA has not posted the shortage to their website because they are working closely with the drug manufacturers to try and prevent supply impact.  The American Society of Health-System Pharmacists has posted details about the shortage on their website, which is linked in the list below.  If you have any questions or concerns, please contact ASH or the FDA’s drug shortage office.

 

back to top

Current Hematologic Drug Shortages

back to top

Recently Resolved Hematologic Drug Shortages

back to top

Additional Resources

back to top

ASH's Comments to Congress and the U.S. Food and Drug Administration

back to top

Media Coverage of Drug Shortages

back to top